Urgences Néphrologiques et Transplantation Rénale, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, Paris, France.
Nephrol Dial Transplant. 2013 Jun;28(6):1362-70. doi: 10.1093/ndt/gfs606. Epub 2013 Jan 24.
Renal transplantation is the best option for patients with end-stage renal disease (ESRD), but its half-life is limited to a decade. Clinical and histological markers measurable within the first year of transplantation can be used to predict its outcome. These markers are important for selecting kidneys for transplantation, for identifying the main causes of late allograft loss, for therapeutic decisions and as surrogate markers in therapeutic trials. 'Basal state' markers, such as age, glomerular filtration rate and fibrotic lesions, are highly predictive of allograft loss, showing that early and stable pathological mechanisms contribute considerably to this loss. On the other hand, some more dynamic predictors such as treatment, recurrence of the initial disease, inflammation and epithelial phenotypic changes offer clinicians and researchers opportunities to influence the fate of allografts.
肾移植是终末期肾病(ESRD)患者的最佳选择,但它的半衰期仅限于十年。可在移植后第一年测量的临床和组织学标志物可用于预测其结果。这些标志物对于选择移植的肾脏、确定晚期移植物丢失的主要原因、治疗决策以及作为治疗试验的替代标志物都很重要。“基础状态”标志物,如年龄、肾小球滤过率和纤维化病变,对移植物丢失具有高度预测性,表明早期和稳定的病理机制对这种丢失有很大影响。另一方面,一些更具动态性的预测指标,如治疗、初始疾病的复发、炎症和上皮表型改变,为临床医生和研究人员提供了影响移植物命运的机会。